Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2018

Open Access 01-12-2018 | Research article

Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition

Authors: Trevor Burger, Tsholofelo Mokoka, Gerda Fouché, Paul Steenkamp, Vanessa Steenkamp, Werner Cordier

Published in: BMC Complementary Medicine and Therapies | Issue 1/2018

Login to get access

Abstract

Background

Solanum aculeastrum fruits are used by some cancer sufferers as a form of alternative treatment. Scientific literature is scarce concerning its anticancer activity, and thus the aim of the study was to assess the in vitro anticancer and P-glycoprotein inhibitory potential of extracts of S. aculeastrum fruits. Furthermore, assessment of the combinational effect with doxorubicin was also done.

Methods

The crude extract was prepared by ultrasonic maceration. Liquid-liquid extraction yielded one aqueous and two organic fractions. Bioactive constituents were isolated from the aqueous fraction by means of column chromatography, solid phase extraction and preparative thin-layer chromatography. Confirmation of bioactive constituent identity was done by nuclear magnetic resonance and ultra-performance liquid chromatography mass spectrometry. The crude extract and fractions were assessed for cytotoxicity and P-glycoprotein inhibition in both cancerous and non-cancerous cell lines using the sulforhodamine B and rhodamine-123 assays, respectively.

Results

Both the crude extract and aqueous fraction was cytotoxic to all cell lines, with the SH-SY5Y neuroblastoma cell line being most susceptible to exposure (IC50 = 10.72 μg/mL [crude], 17.21 μg/mL [aqueous]). Dose-dependent P-glycoprotein inhibition was observed for the crude extract (5.9 to 18.9-fold at 100 μg/mL) and aqueous fraction (2.9 to 21.2 at 100 μg/mL). The steroidal alkaloids solamargine and solanine were identified. While solanine was not bioactive, solamargine displayed an IC50 of 15.62 μg/mL, and 9.1-fold P-glycoprotein inhibition at 100 μg/mL against the SH-SY5Y cell line. Additive effects were noted for combinations of doxorubicin against the SH-SY5Y cell line.

Conclusions

The crude extract and aqueous fraction displayed potent non-selective cytotoxicity and noteworthy P-glycoprotein inhibition. These effects were attributed to solamargine. P-glycoprotein inhibitory activity was only present at concentrations higher than those inducing cytotoxicity, and thus does not appear to be the likely mechanism for the enhancement of doxorubicin’s cytotoxicity. Preliminary results suggest that non-selective cytotoxicity may hinder drug development, however, further assessment of the mode of cell death is necessary to determine the route forward.
Literature
1.
go back to reference Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2012;62:220–41.CrossRefPubMed Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C. Cancer treatment and survivorship statistics. CA Cancer J Clin. 2012;62:220–41.CrossRefPubMed
3.
go back to reference Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse effects and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006;15:23–31.CrossRefPubMedPubMedCentral Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse effects and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care. 2006;15:23–31.CrossRefPubMedPubMedCentral
4.
go back to reference Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27:3868–74.CrossRefPubMed Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27:3868–74.CrossRefPubMed
5.
go back to reference Bock C, Lengauer T. Managing drug resistance in cancer: lessons from HIV therapy. Nat Rev Cancer. 2012;12:494–501.CrossRefPubMed Bock C, Lengauer T. Managing drug resistance in cancer: lessons from HIV therapy. Nat Rev Cancer. 2012;12:494–501.CrossRefPubMed
6.
go back to reference Liu FS. Mechanisms of chemotherapeutic drug resistance in cancer therapy-a quick review. Taiwan J Obstet Gynecol. 2009;48:239–44.CrossRefPubMed Liu FS. Mechanisms of chemotherapeutic drug resistance in cancer therapy-a quick review. Taiwan J Obstet Gynecol. 2009;48:239–44.CrossRefPubMed
7.
8.
go back to reference Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW. In-vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos. 2006;34:786–92.CrossRefPubMed Rautio J, Humphreys JE, Webster LO, Balakrishnan A, Keogh JP, Kunta JR, Serabjit-Singh CJ, Polli JW. In-vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates. Drug Metab Dispos. 2006;34:786–92.CrossRefPubMed
9.
go back to reference Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, Serabjit-Singh CS. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther. 2001;299:620–8.PubMed Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, Serabjit-Singh CS. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther. 2001;299:620–8.PubMed
10.
go back to reference Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer. 2004;4:423–36.CrossRefPubMed Kerbel RS, Kamen BA. The anti-angiogenic basis of metronomic chemotherapy. Nat Rev Cancer. 2004;4:423–36.CrossRefPubMed
11.
go back to reference Jacquin JP, Chargari C, Thorin J, Mille D, Mélis A, Orfeuvre H, Clavreul G, Chaigneau L, Nourissat A, Dumanoir C, Savary J, Merrouche Y, Magné N. Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients. Am J Clin Oncol. 2012;35:18–21.CrossRefPubMed Jacquin JP, Chargari C, Thorin J, Mille D, Mélis A, Orfeuvre H, Clavreul G, Chaigneau L, Nourissat A, Dumanoir C, Savary J, Merrouche Y, Magné N. Phase II trial of pegylated liposomal doxorubicin in combination with gemcitabine in metastatic breast cancer patients. Am J Clin Oncol. 2012;35:18–21.CrossRefPubMed
12.
go back to reference da Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol. 2001;1:364–9.CrossRefPubMed da Rocha AB, Lopes RM, Schwartsmann G. Natural products in anticancer therapy. Curr Opin Pharmacol. 2001;1:364–9.CrossRefPubMed
13.
go back to reference Cuellar N, Aycock T, Cahill B, Ford J. Complementary and alternative medicine (CAM) use by African American (AA) and Caucasian American (CA) older adults in a rural setting: a descriptive, comparative study. BMC Complement Altern Med. 2013;3:8–14.CrossRef Cuellar N, Aycock T, Cahill B, Ford J. Complementary and alternative medicine (CAM) use by African American (AA) and Caucasian American (CA) older adults in a rural setting: a descriptive, comparative study. BMC Complement Altern Med. 2013;3:8–14.CrossRef
14.
go back to reference Kaur R, Kapoor K, Kaur H. Plants as a source of anticancer agents. J Nat Prod Plant Resour. 2001;1:119–24. Kaur R, Kapoor K, Kaur H. Plants as a source of anticancer agents. J Nat Prod Plant Resour. 2001;1:119–24.
15.
go back to reference Shu L, Cheung KL, Khor TO, Chen C, Kong AN. Phytochemicals: cancer chemoprevention and suppression of tumour onset and metastasis. Cancer Metastasis Rev. 2010;29:483–502.CrossRefPubMed Shu L, Cheung KL, Khor TO, Chen C, Kong AN. Phytochemicals: cancer chemoprevention and suppression of tumour onset and metastasis. Cancer Metastasis Rev. 2010;29:483–502.CrossRefPubMed
16.
go back to reference Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine. 2009;4:99–105.PubMedPubMedCentral Miele E, Spinelli GP, Miele E, Tomao F, Tomao S. Albumin-bound formulation of paclitaxel (Abraxane ABI-007) in the treatment of breast cancer. Int J Nanomedicine. 2009;4:99–105.PubMedPubMedCentral
17.
go back to reference Koduru S, Grierson DS, van de Venter M, Afolayan AJ. In vitro antitumour activity of Solanum aculeastrum berries on three carcinoma cells. Int J Cancer Res. 2006;4:397–402. Koduru S, Grierson DS, van de Venter M, Afolayan AJ. In vitro antitumour activity of Solanum aculeastrum berries on three carcinoma cells. Int J Cancer Res. 2006;4:397–402.
18.
go back to reference Drewes FE, van Staden J. Aspects of the extraction and purification of solasodine from Solanum aculeastrum tissues. Phytochem Anal. 1995;6:203–6.CrossRef Drewes FE, van Staden J. Aspects of the extraction and purification of solasodine from Solanum aculeastrum tissues. Phytochem Anal. 1995;6:203–6.CrossRef
19.
go back to reference Wanyonyi AW, Sumesh CC, Gerld M, Udo E, Wilson MN. Bioactive steroidal alkaloid glycosides from Solanum aculeastrum. Phytochemistry. 2002;59:79–84.CrossRefPubMed Wanyonyi AW, Sumesh CC, Gerld M, Udo E, Wilson MN. Bioactive steroidal alkaloid glycosides from Solanum aculeastrum. Phytochemistry. 2002;59:79–84.CrossRefPubMed
20.
go back to reference Munari CC, de Oliveira PF, Campos JCL, Martins SP, da Costa JC, Bastos JK, Tavares DC. Antiproliferative activity of Solanum lycocarpum alkaloidic extract and their constituents, solamargine and solasonine, in tumor cell lines. J Nat Med. 2004;68:236–41.CrossRef Munari CC, de Oliveira PF, Campos JCL, Martins SP, da Costa JC, Bastos JK, Tavares DC. Antiproliferative activity of Solanum lycocarpum alkaloidic extract and their constituents, solamargine and solasonine, in tumor cell lines. J Nat Med. 2004;68:236–41.CrossRef
21.
go back to reference Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1:1112–6.CrossRefPubMed Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006;1:1112–6.CrossRefPubMed
22.
go back to reference Jia JX, Wasan KM. Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells. J Pharm Pharm Sci. 2008;11:45–62.CrossRefPubMed Jia JX, Wasan KM. Effects of monoglycerides on rhodamine 123 accumulation, estradiol 17 beta-D-glucuronide bidirectional transport and MRP2 protein expression within Caco-2 cells. J Pharm Pharm Sci. 2008;11:45–62.CrossRefPubMed
23.
go back to reference Kars MD, Gündüz U, Üney K, Baş AL. Exploring a natural MDR reversal agent: potential of medical food supplement Nerium oleander leaf distillate. Asian Pac J Trop Biomed. 2013;3:644–9.CrossRefPubMedPubMedCentral Kars MD, Gündüz U, Üney K, Baş AL. Exploring a natural MDR reversal agent: potential of medical food supplement Nerium oleander leaf distillate. Asian Pac J Trop Biomed. 2013;3:644–9.CrossRefPubMedPubMedCentral
24.
go back to reference Flieger J. Alkaloids/thin-layer (planar) chromatography, in: Encyclopedia of Separation Science., New York, 2000;pp. 1956–73. Flieger J. Alkaloids/thin-layer (planar) chromatography, in: Encyclopedia of Separation Science., New York, 2000;pp. 1956–73.
25.
go back to reference Sreevidya N, Mehrotra S. Spectrophotometric method for estimation of alkaloids precipitable with Dragendorff's reagent in plant materials. J AOAC Int. 2003;86:1124–7.PubMed Sreevidya N, Mehrotra S. Spectrophotometric method for estimation of alkaloids precipitable with Dragendorff's reagent in plant materials. J AOAC Int. 2003;86:1124–7.PubMed
26.
go back to reference Koduru S, Jimoh FO, Grierson DS, Afolayan AJ. Antioxidant activity of two steroid alkaloids extract from Solanum aculeastrum. J Toxicol Pharmacol. 2007;2:160–7.CrossRef Koduru S, Jimoh FO, Grierson DS, Afolayan AJ. Antioxidant activity of two steroid alkaloids extract from Solanum aculeastrum. J Toxicol Pharmacol. 2007;2:160–7.CrossRef
27.
go back to reference Neszmelyi A, Machytka D, Shabana MM. 13C NMR spectroscopy of solasodine glycosides from Solanum laciniatum. Phytochemistry. 1988;27:603–5.CrossRef Neszmelyi A, Machytka D, Shabana MM. 13C NMR spectroscopy of solasodine glycosides from Solanum laciniatum. Phytochemistry. 1988;27:603–5.CrossRef
28.
go back to reference Blankemeyer JT, Mc-Williams ML, Rayburn JR, Weissenberg M, Friedman M. Developmental toxicology of solamargine glycoalkaloids in frog embryos. Food Chem Toxicol. 1998;36:383–9.CrossRefPubMed Blankemeyer JT, Mc-Williams ML, Rayburn JR, Weissenberg M, Friedman M. Developmental toxicology of solamargine glycoalkaloids in frog embryos. Food Chem Toxicol. 1998;36:383–9.CrossRefPubMed
29.
go back to reference Nikolic NC, Stankovic MZ. Solanidine hydrolytic extraction and separation from the potato (Solanum tuberosum L.) vines by using solid-liquid-liquid systems. J Agric Food Chem. 2003;51:1845–9.CrossRefPubMed Nikolic NC, Stankovic MZ. Solanidine hydrolytic extraction and separation from the potato (Solanum tuberosum L.) vines by using solid-liquid-liquid systems. J Agric Food Chem. 2003;51:1845–9.CrossRefPubMed
30.
go back to reference Al-Rehaily AJ, Ahmad MS, Mustafa J, Al-Oqail MM, Hassan WH, Khan SI, Ikhlas AK. Solanopubamine, a rare steroidal alkaloid from Solanum schimperianum: synthesis of some new alkyl and acyl derivatives, their anticancer and antimicrobial evaluation. J Saudi Chem Soc. 2013;17:67–76.CrossRef Al-Rehaily AJ, Ahmad MS, Mustafa J, Al-Oqail MM, Hassan WH, Khan SI, Ikhlas AK. Solanopubamine, a rare steroidal alkaloid from Solanum schimperianum: synthesis of some new alkyl and acyl derivatives, their anticancer and antimicrobial evaluation. J Saudi Chem Soc. 2013;17:67–76.CrossRef
31.
go back to reference Lin HM, Tseng HC, Wang CJ, Chyau CC, Liao KK, Peng PL, Chou FP. Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J Agric Food Chem. 2007;55:3620–8.CrossRefPubMed Lin HM, Tseng HC, Wang CJ, Chyau CC, Liao KK, Peng PL, Chou FP. Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J Agric Food Chem. 2007;55:3620–8.CrossRefPubMed
32.
go back to reference Yu S, Sheu H-M, Lee C-H. Solanum incanum extract (ST-100) induced melanoma cell apoptosis and inhibits established lung metastasis. Oncotarget. 2017;8:103509–17.PubMedPubMedCentral Yu S, Sheu H-M, Lee C-H. Solanum incanum extract (ST-100) induced melanoma cell apoptosis and inhibits established lung metastasis. Oncotarget. 2017;8:103509–17.PubMedPubMedCentral
33.
go back to reference Kuo KW, Hsu SH, Li YP, Lin WL, Liu LF, Chang LC, Lin CC, Lin CN, Sheu HM. Anticancer activity evaluation of the Solanum glycoalkaloid solamargine: triggering apoptosis in human hepatoma cells. Biochem Pharmacol. 2000;60:1865–73.CrossRefPubMed Kuo KW, Hsu SH, Li YP, Lin WL, Liu LF, Chang LC, Lin CC, Lin CN, Sheu HM. Anticancer activity evaluation of the Solanum glycoalkaloid solamargine: triggering apoptosis in human hepatoma cells. Biochem Pharmacol. 2000;60:1865–73.CrossRefPubMed
34.
go back to reference Shiu LY, Chang LC, Liang CH, Huang YS, Sheu HM, Kuo KW. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. Food Chem Toxicol. 2007;45:2155–64.CrossRefPubMed Shiu LY, Chang LC, Liang CH, Huang YS, Sheu HM, Kuo KW. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. Food Chem Toxicol. 2007;45:2155–64.CrossRefPubMed
35.
go back to reference Chen Y, Tang Q, Xiao Q, Yang L, Hann SS. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells. J Cell Mol Med. 2017;21:223–33. Chen Y, Tang Q, Xiao Q, Yang L, Hann SS. Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells. J Cell Mol Med. 2017;21:223–33.
36.
go back to reference Xie X, Zhu H, Zhang J, Wang M, Zhu L, Guo Z, Shen W, Wang D. Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition. Oncol Lett. 2017;14:447–52.CrossRefPubMedPubMedCentral Xie X, Zhu H, Zhang J, Wang M, Zhu L, Guo Z, Shen W, Wang D. Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition. Oncol Lett. 2017;14:447–52.CrossRefPubMedPubMedCentral
37.
go back to reference Esteves-Souza A, da Silva TMS, Alves CCF, de Carvalho MG, Braz-Filho R, Aurea E. Cytotoxic activities against Ehrlich carcinoma and human k562 leukaemia of alkaloids and flavonoid from two Solanum species. Braz Chem Soc. 2002;13:838–42.CrossRef Esteves-Souza A, da Silva TMS, Alves CCF, de Carvalho MG, Braz-Filho R, Aurea E. Cytotoxic activities against Ehrlich carcinoma and human k562 leukaemia of alkaloids and flavonoid from two Solanum species. Braz Chem Soc. 2002;13:838–42.CrossRef
38.
go back to reference Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T, Tanaka M. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci U S A. 2009;106:9679–84.CrossRefPubMedPubMedCentral Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T, Tanaka M. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci U S A. 2009;106:9679–84.CrossRefPubMedPubMedCentral
39.
go back to reference Junyaprasert VB, Soonthornchareonnon N, Thongpraditchote S, Murakami T, Takano M. Inhibitory effect of Thai plant extracts on P-glycoprotein mediated efflux. Phytother Res. 2006;20:79–81.CrossRefPubMed Junyaprasert VB, Soonthornchareonnon N, Thongpraditchote S, Murakami T, Takano M. Inhibitory effect of Thai plant extracts on P-glycoprotein mediated efflux. Phytother Res. 2006;20:79–81.CrossRefPubMed
40.
go back to reference Sahu J, Rathi B, Koul S, Khosa RL. Solanum trilobatum (Solanaceae)-an overview. J Nat Remedies. 2013;13:76–80. Sahu J, Rathi B, Koul S, Khosa RL. Solanum trilobatum (Solanaceae)-an overview. J Nat Remedies. 2013;13:76–80.
41.
go back to reference Li X, Zhao Y, Ji M, Liu SS, Cui M, Lou HX. Induction of actin disruption and downregulation of P-glycoprotein expression by solamargine in multidrug-resistant K562/A02 cells. Chin Med J. 2011;124:2038–44.PubMed Li X, Zhao Y, Ji M, Liu SS, Cui M, Lou HX. Induction of actin disruption and downregulation of P-glycoprotein expression by solamargine in multidrug-resistant K562/A02 cells. Chin Med J. 2011;124:2038–44.PubMed
42.
go back to reference Lavie YA, Harel-Orbital TO, Gaffield WI, Liscovitch MO. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. Anticancer Res. 2001;21:1189–94.PubMed Lavie YA, Harel-Orbital TO, Gaffield WI, Liscovitch MO. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. Anticancer Res. 2001;21:1189–94.PubMed
43.
go back to reference Shapiro AB, Ling V. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem. 1997;250:130–7.CrossRefPubMed Shapiro AB, Ling V. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem. 1997;250:130–7.CrossRefPubMed
44.
go back to reference Jia J, Zhu F, Ma X, Cao ZW, Li YX, Chen YZ. Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov. 2009;8:111–28.CrossRefPubMed Jia J, Zhu F, Ma X, Cao ZW, Li YX, Chen YZ. Mechanisms of drug combinations: interaction and network perspectives. Nat Rev Drug Discov. 2009;8:111–28.CrossRefPubMed
45.
go back to reference Tai CJ, Wang CK, Tai CJ, Lin YF, Lin CS, Jian JY, Chang YJ, Chang CC. Aqueous extract of Solanum nigrum leaves induces autophagy and enhances cytotoxicity of cisplatin, doxorubicin, docetaxel, and 5-fluorouracil in human colorectal carcinoma cells. Evid Based Complement Alternat Med. 2013:1–12. Tai CJ, Wang CK, Tai CJ, Lin YF, Lin CS, Jian JY, Chang YJ, Chang CC. Aqueous extract of Solanum nigrum leaves induces autophagy and enhances cytotoxicity of cisplatin, doxorubicin, docetaxel, and 5-fluorouracil in human colorectal carcinoma cells. Evid Based Complement Alternat Med. 2013:1–12.
46.
go back to reference Anindyajati S, Putri DD, Hermawan A, Meiyanto E. Combination of Solanum nigrum L. herb ethanolic extract and doxorubicin performs synergism on T47D breast cancer cells. Indones J Chemoprev. 2010;1(2):78–84. Anindyajati S, Putri DD, Hermawan A, Meiyanto E. Combination of Solanum nigrum L. herb ethanolic extract and doxorubicin performs synergism on T47D breast cancer cells. Indones J Chemoprev. 2010;1(2):78–84.
47.
go back to reference Ding X, Zhu FS, Li M, Gao SG. Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. J Ethnopharmacol. 2012;139:599–604.CrossRefPubMed Ding X, Zhu FS, Li M, Gao SG. Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. J Ethnopharmacol. 2012;139:599–604.CrossRefPubMed
48.
go back to reference Liang CH, Liu LF, Shiu LY, Huang YS, Chang LC, Kuo KW. Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells. Biochem Biophys Res Commun. 2004;322:751–8.CrossRefPubMed Liang CH, Liu LF, Shiu LY, Huang YS, Chang LC, Kuo KW. Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells. Biochem Biophys Res Commun. 2004;322:751–8.CrossRefPubMed
49.
go back to reference Friedman M, Lee KR, Kim HJ, Lee IS, Kozukue N. Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells. J Agric Food Chem. 2005;53:6162–9.CrossRefPubMed Friedman M, Lee KR, Kim HJ, Lee IS, Kozukue N. Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells. J Agric Food Chem. 2005;53:6162–9.CrossRefPubMed
50.
go back to reference Xu Y, Zhi F, Xu G, Tang X, Lu S, Wu J, Hu Y. Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416. Biosci Rep. 2012;32:559–66.CrossRefPubMedPubMedCentral Xu Y, Zhi F, Xu G, Tang X, Lu S, Wu J, Hu Y. Overcoming multidrug-resistance in vitro and in vivo using the novel P-glycoprotein inhibitor 1416. Biosci Rep. 2012;32:559–66.CrossRefPubMedPubMedCentral
51.
go back to reference El-Readi MZ, Hamdan D, Farrag N, El-Shazly A, Wink M. Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. Eur J Pharmacol. 2010;626:139–45.CrossRefPubMed El-Readi MZ, Hamdan D, Farrag N, El-Shazly A, Wink M. Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. Eur J Pharmacol. 2010;626:139–45.CrossRefPubMed
Metadata
Title
Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition
Authors
Trevor Burger
Tsholofelo Mokoka
Gerda Fouché
Paul Steenkamp
Vanessa Steenkamp
Werner Cordier
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2018
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-018-2208-7

Other articles of this Issue 1/2018

BMC Complementary Medicine and Therapies 1/2018 Go to the issue